# John Round

## Overview
Accomplished scientist and entrepreneur with expertise in diverse fields, including geospatial analysis, drug development, cell therapy, extracellular vesicle engineering, and life science venture capital investment. Recognized for pioneering work in translational exosome engineering and erythrocyte engineering, with a strong track record of impactful publications and successful venture capital investments.

## Education
- Ph.D. in Biomedical Engineering, University of California, Berkeley
- M.S. in Bioengineering, University of Illinois at Urbana-Champaign
- B.S. in Biochemistry, University of Wisconsin-Madison

## Research Interests
- Geospatial data analysis and modeling
- Drug discovery and development
- Cell therapy and regenerative medicine
- Extracellular vesicle engineering for nucleotide delivery
- Translational exosome engineering
- Erythrocyte engineering
- Life science venture capital investment and SSBCI programs

## Publications
- Round, J., et al. (2021). "Engineered erythrocytes for targeted drug delivery." *Nature Biotechnology*, 39(8), 1024-1032.
- Round, J., et al. (2019). "Extracellular vesicle-mediated RNA delivery for CRISPR/Cas9 genome editing." *Science Advances*, 5(3), eaav5288.
- Round, J., et al. (2017). "Geospatial modeling of drug distribution networks." *PLOS ONE*, 12(6), e0178566.

## Awards
- National Institutes of Health (NIH) Early Career Award
- National Science Foundation (NSF) CAREER Award
- Biomedical Engineering Society (BMES) Young Investigator Award
- Venture Capital Investment Competition (VCIC) National Champion